RATIONALE: Cardioprotective signaling mediates antiapoptotic actions through multiple mechanisms including maintenance of mitochondrial integrity. Pim-1 kinase is an essential downstream effector of AKT-mediated cardioprotection but the mechanistic basis for maintenance of mitochondrial integrity by Pim-1 remains unexplored. This study details antiapoptotic actions responsible for enhanced cell survival in cardiomyocytes with elevated Pim-1 activity. OBJECTIVE: The purpose of this study is to demonstrate that the cardioprotective kinase Pim-1 acts to inhibit cell death by preserving mitochondrial integrity in cardiomyocytes. METHODS AND RESULTS: A combination of biochemical, molecular, and microscopic analyses demonstrate beneficial effects of Pim-1 on mitochondrial integrity. Pim-1 protein level increases in the mitochondrial fraction with a corresponding decrease in the cytosolic fraction of myocardial lysates from hearts subjected to 30 minutes of ischemia followed by 30 minutes of reperfusion. Cardiac-specific overexpression of Pim-1 results in higher levels of antiapoptotic Bcl-X(L) and Bcl-2 compared to samples from normal hearts. In response to oxidative stress challenge, Pim-1 preserves the inner mitochondrial membrane potential. Ultrastructure of the mitochondria is maintained by Pim-1 activity, which prevents swelling induced by calcium overload. Finally, mitochondria isolated from hearts created with cardiac-specific overexpression of Pim-1 show inhibition of cytochrome c release triggered by a truncated form of proapoptotic Bid. CONCLUSION: Cardioprotective action of Pim-1 kinase includes preservation of mitochondrial integrity during cardiomyopathic challenge conditions, thereby raising the potential for Pim-1 kinase activation as a therapeutic interventional approach to inhibit cell death by antagonizing proapoptotic Bcl-2 family members that regulate the intrinsic apoptotic pathway.
RATIONALE: Cardioprotective signaling mediates antiapoptotic actions through multiple mechanisms including maintenance of mitochondrial integrity. Pim-1 kinase is an essential downstream effector of AKT-mediated cardioprotection but the mechanistic basis for maintenance of mitochondrial integrity by Pim-1 remains unexplored. This study details antiapoptotic actions responsible for enhanced cell survival in cardiomyocytes with elevated Pim-1 activity. OBJECTIVE: The purpose of this study is to demonstrate that the cardioprotective kinase Pim-1 acts to inhibit cell death by preserving mitochondrial integrity in cardiomyocytes. METHODS AND RESULTS: A combination of biochemical, molecular, and microscopic analyses demonstrate beneficial effects of Pim-1 on mitochondrial integrity. Pim-1 protein level increases in the mitochondrial fraction with a corresponding decrease in the cytosolic fraction of myocardial lysates from hearts subjected to 30 minutes of ischemia followed by 30 minutes of reperfusion. Cardiac-specific overexpression of Pim-1 results in higher levels of antiapoptotic Bcl-X(L) and Bcl-2 compared to samples from normal hearts. In response to oxidative stress challenge, Pim-1 preserves the inner mitochondrial membrane potential. Ultrastructure of the mitochondria is maintained by Pim-1 activity, which prevents swelling induced by calcium overload. Finally, mitochondria isolated from hearts created with cardiac-specific overexpression of Pim-1 show inhibition of cytochrome c release triggered by a truncated form of proapoptotic Bid. CONCLUSION: Cardioprotective action of Pim-1 kinase includes preservation of mitochondrial integrity during cardiomyopathic challenge conditions, thereby raising the potential for Pim-1 kinase activation as a therapeutic interventional approach to inhibit cell death by antagonizing proapoptotic Bcl-2 family members that regulate the intrinsic apoptotic pathway.
Authors: Teija L T Aho; Jouko Sandholm; Katriina J Peltola; Harri P Mankonen; Michael Lilly; Päivi J Koskinen Journal: FEBS Lett Date: 2004-07-30 Impact factor: 4.124
Authors: Isao Shiraishi; Jaime Melendez; Youngkeun Ahn; Maryanne Skavdahl; Elizabeth Murphy; Sara Welch; Erik Schaefer; Kenneth Walsh; Anthony Rosenzweig; Daniele Torella; Daria Nurzynska; Jan Kajstura; Annarosa Leri; Piero Anversa; Mark A Sussman Journal: Circ Res Date: 2004-02-26 Impact factor: 17.367
Authors: Leta K Nutt; Abujiang Pataer; Jessica Pahler; Bingliang Fang; Jack Roth; David J McConkey; Stephen G Swisher Journal: J Biol Chem Date: 2001-12-06 Impact factor: 5.157
Authors: Charles Steenbergen; Cynthia A Afshari; John G Petranka; Jennifer Collins; Karla Martin; Lee Bennett; Astrid Haugen; Pierre Bushel; Elizabeth Murphy Journal: Am J Physiol Heart Circ Physiol Date: 2002-09-26 Impact factor: 4.733
Authors: Lisa E Morrison; Ross J Whittaker; Robert E Klepper; Eric F Wawrousek; Christopher C Glembotski Journal: Am J Physiol Heart Circ Physiol Date: 2003-10-30 Impact factor: 4.733
Authors: Mathias H Konstandin; Haruhiro Toko; Grady M Gastelum; Pearl Quijada; Andrea De La Torre; Mercedes Quintana; Brett Collins; Shabana Din; Daniele Avitabile; Mirko Völkers; Natalie Gude; Reinhard Fässler; Mark A Sussman Journal: Circ Res Date: 2013-05-07 Impact factor: 17.367
Authors: Kimberlee M Fischer; Christopher T Cottage; Mathias H Konstandin; Mirko Völkers; Mohsin Khan; Mark A Sussman Journal: J Mol Cell Cardiol Date: 2011-01-19 Impact factor: 5.000
Authors: Sadia Mohsin; Mohsin Khan; Haruhiro Toko; Brandi Bailey; Christopher T Cottage; Kathleen Wallach; Divya Nag; Andrew Lee; Sailay Siddiqi; Feng Lan; Kimberlee M Fischer; Natalie Gude; Pearl Quijada; Daniele Avitabile; Silvia Truffa; Brett Collins; Walter Dembitsky; Joseph C Wu; Mark A Sussman Journal: J Am Coll Cardiol Date: 2012-07-26 Impact factor: 24.094
Authors: Shabana Din; Matthew Mason; Mirko Völkers; Bevan Johnson; Christopher T Cottage; Zeping Wang; Anya Y Joyo; Pearl Quijada; Peter Erhardt; Nancy S Magnuson; Mathias H Konstandin; Mark A Sussman Journal: Proc Natl Acad Sci U S A Date: 2013-03-25 Impact factor: 11.205